HD-SLEEP2: Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions - 2

Sponsor
Pennington Biomedical Research Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05102188
Collaborator
National Institute of General Medical Sciences (NIGMS) (NIH)
80
1
9.7
8.3

Study Details

Study Description

Brief Summary

The purpose of the HD-SLEEP2 study is to help researchers understand sleep in African Americans. The investigators also want to know what factors may affect sleep.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Assessment of sleep and related factors

Detailed Description

African Americans who self-report poor sleep (n=80) will be invited to complete questionnaire based self-assessment of known factors and comorbidities contributing to alterations in sleep such as demographic characteristics, anthropometrics, depression, insomnia, and food habits in conjunction with objective and subjective measures of sleep via 7-day accelerometry (sleep duration), overnight oximetry (sleep apnea), and sleep questionnaires.

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Addressing Health Disparities in African Americans - Exploring Sleep and Developing Interventions -2
Actual Study Start Date :
Mar 11, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
African American adults with poor sleep

Individuals with self-identified poor sleep quality and/or quantity

Combination Product: Assessment of sleep and related factors
Eligible participants will be invited to fill out several forms and wear a watch-like device on their wrist (an accelerometer) for 7 days to assess their sleep habits. They will also be asked to sleep at home with a watch-like device attached to a sleeve which covers their index finger (an oximeter) for one night to assess whether they may have a sleep problem like sleep apnea.

Outcome Measures

Primary Outcome Measures

  1. Habitual sleep duration [7 days]

    Average hours of sleep/24h period

  2. Oxygen desaturation index [1 day]

    Number of oxygen desaturation events per hour of sleep

  3. Sleep Quality [1 day]

    Sleep quality as determined by Pittsburgh Sleep Quality Index. The minimum score is 0 and maximum score is 21. Higher scores indicate poor sleep quality.

  4. Daytime Sleepiness [1 day]

    Severity of daytime sleepiness as determined by Epworth Sleepiness scale. The minimum score is 0 and maximum score is 24. Higher scores suggest daytime sleepiness.

  5. Sleep behaviors [1 day]

    Sleep hygiene behaviors as determined by sleep hygiene index. The minimum score is 13 and maximum score is 65. Higher scores indicate poor sleep hygiene status.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Self-identified African American

  • Age range: >18 years (inclusive)

  • Sex: Both males and females will be allowed to participate in the study

  • Self-perceived poor sleep

Exclusion Criteria:
  • Unable to provide written informed consent

  • Unable to understand English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Recruiting core Pennington Baton Rouge Louisiana United States 70808

Sponsors and Collaborators

  • Pennington Biomedical Research Center
  • National Institute of General Medical Sciences (NIGMS)

Investigators

  • Principal Investigator: Prachi Singh, PhD, Pennington Biomedical Research Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prachi Singh, Associate Professor, Sleep and Cardiometabolic Health, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier:
NCT05102188
Other Study ID Numbers:
  • PBRC 2020-020-2
  • U54GM104940
First Posted:
Nov 1, 2021
Last Update Posted:
Mar 15, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Prachi Singh, Associate Professor, Sleep and Cardiometabolic Health, Pennington Biomedical Research Center

Study Results

No Results Posted as of Mar 15, 2022